1
|
Boudiaf Z, Kheloufi M, Bentabak K. Gastric pouch interposition after excision of an ileal pouch following septic complications: An alternative to definitive ileostomy. J Visc Surg 2023; 160:389-391. [PMID: 37659964 DOI: 10.1016/j.jviscsurg.2023.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/04/2023]
Affiliation(s)
- Zaki Boudiaf
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad-Salem, 16000 Algiers, Algeria; Faculty of medicine, University of Algiers Benyoucef-Benkhedda, Algiers, Algeria.
| | - Mohand Kheloufi
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad-Salem, 16000 Algiers, Algeria; Faculty of medicine, University of Algiers Benyoucef-Benkhedda, Algiers, Algeria
| | - Kamel Bentabak
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad-Salem, 16000 Algiers, Algeria; Faculty of medicine, University of Algiers Benyoucef-Benkhedda, Algiers, Algeria
| |
Collapse
|
2
|
Boudiaf Z, Bouzid C, Ait-arab MR, Cherchar K, Kheloufi M, Chibane A, Boutekedjiret IH, Hattou Z, Gouaref F, Bentabak K. [Laparoscopic downstaging surgery for colorectal cancer with synchronous liver metastases: what value in two-stage hepatectomies?]. Pan Afr Med J 2023; 46:38. [PMID: 38145195 PMCID: PMC10746878 DOI: 10.11604/pamj.2023.46.38.35775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Accepted: 09/13/2023] [Indexed: 12/26/2023] Open
Abstract
Bilobar hepatic metastases from colorectal cancer pose a problem in terms of management, with curative surgery often requiring several stages. The purpose of our study was to evaluate laparoscopic approach with portal vein ligation in the first step of two-stage hepatectomy in the treatment of patients with synchronous liver metastases from colorectal cancers (SLMCRC). We conducted a single-center retrospective study from August 2016 to January 2020. It included patients with SLMCRC requiring two-stage curative surgery due to insufficient future liver remnant volume (FRL). The primary endpoint was to evaluate postoperative morbidity and mortality following first step laparoscopy at 30 days. The secondary endpoints were to evaluate conversion rate, FRL hypertrophy following laparoscopic portal vein ligation, postoperative morbidity and mortality of 2nd step of two-stage hepatectomy and finally treatment completion rate. We included six patients (4 men and 2 women) with a mean age of 64 (44-72) years. The first step of surgery consisted of a laparoscopic colonic resection associated with right portal vein ligation in 5 patients and left portal vein ligation in one patient. The postoperative morbimortality was zero. The conversion rate was zero. After portal vein ligation, 5 of the 6 patients had significantly enlarged FRL, with a mean gain in FRL volume of 59.48% (31.02%-68.71%). Two of the six patients had severe morbidity after 2nd step hepatectomy (Clavien IIIb). All patients completed the treatment.
Collapse
Affiliation(s)
- Zaki Boudiaf
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Chafik Bouzid
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Mohamed Rafik Ait-arab
- Etablissement Hospitalier Spécialisé en Lutte Contre le Cancer de Blida, Blida, Algérie
- Faculté de Médecine, Université Saad Dahleb Blida I, Blida, Algérie
| | - Karim Cherchar
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Mohand Kheloufi
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Aissam Chibane
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Ihsene Hatem Boutekedjiret
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Zakia Hattou
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Fatiha Gouaref
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| | - Kamel Bentabak
- Service de Chirurgie Oncologique A, Centre Pierre et Marie Curie (CPMC), Avenue Bouzenad Salem, 16000 Alger, Algérie
- Faculté de Médecine d´Alger, Université Benyoucef Benkhedda, Alger, Algérie
| |
Collapse
|
3
|
Boudiaf Z, Cherchar K, Bouzid C, Bentabak K. Re: "Laparoscopic Resection of Colon Cancer and Synchronous Liver Metastasis" by Geiger, et al. J Laparoendosc Adv Surg Tech A 2022; 32:1131-1132. [PMID: 36126308 DOI: 10.1089/lap.2022.0363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Zaki Boudiaf
- Department of Oncological Surgery, Centre Pierre et Marie Curie, Algiers, Algeria.,Faculty of Medicine, University of Algiers Benyoucef Benkhedda, Algiers, Algeria
| | - Karim Cherchar
- Department of Oncological Surgery, Centre Pierre et Marie Curie, Algiers, Algeria.,Faculty of Medicine, University of Algiers Benyoucef Benkhedda, Algiers, Algeria
| | - Chafik Bouzid
- Department of Oncological Surgery, Centre Pierre et Marie Curie, Algiers, Algeria.,Faculty of Medicine, University of Algiers Benyoucef Benkhedda, Algiers, Algeria
| | - Kamel Bentabak
- Department of Oncological Surgery, Centre Pierre et Marie Curie, Algiers, Algeria.,Faculty of Medicine, University of Algiers Benyoucef Benkhedda, Algiers, Algeria
| |
Collapse
|
4
|
Boudiaf Z, Bouzid C, Cherchar K, Chibane A, Kheloufi M, Boutekedjiret IH, Hattou Z, Bentabak K. Outcomes of Laparoscopic Combined Surgery for Colorectal Cancer with Synchronous Liver Metastases: A Prospective Comparative Study. Gulf J Oncolog 2022; 1:47-55. [PMID: 35695346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2021] [Indexed: 06/15/2023]
Abstract
AIM Combined surgery for colorectal cancer with synchronous liver metastases (CRCSLM) is addressed to selected patients. Technically, by conventional surgery this simultaneous approach raises a problem of adequate access. The purpose of this study is to assess the feasibility and safety of the laparoscopic approach in combined surgery. METHODS From August 2016 to January 2020 a monocentric prospective comparative study was conducted. Short and long-term outcomes of simultaneous laparoscopic surgery (SLS) were evaluated. Short-term outcomes of SLS were compared to those of laparoscopic colorectal surgery alone (LCRS). RESULTS Forty patients were included in each arm. In SLS group, the median age was 62.5 years. Hybrid surgery was performed for 60% of patients, down staging laparoscopic surgery for 22.5% of patients and totally laparoscopic surgery for 10% of patients. The conversion rate was 7.5%. Mean operating time was 323 minutes. Overall morbidity rate was 27.5%. Multivariate analysis showed that anemia (p = 0.046) and number of liver resections (p = 0.018) were independent factors of morbidity. Ninety-five percent of colorectal resections were R0, 90% of liver resections were R0. The mean length of hospital stay was 5.1 ± 2.58 days. The recurrence rate was 22.5%. Median diseasefree survival was 27 months. There was no difference in short-term outcomes between the two arms except for operating time which was longer in SLS arm (p < 0.0005). CONCLUSION Laparoscopy is feasible in combined surgery in selected patients. Minor liver resection may be associated with laparoscopic colorectal surgery without increasing morbidity.
Collapse
Affiliation(s)
- Zaki Boudiaf
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Chafik Bouzid
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Karim Cherchar
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Aissam Chibane
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Mohand Kheloufi
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Ihsene Hatem Boutekedjiret
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Zakia Hattou
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| | - Kamel Bentabak
- Department of Oncological Surgery, Centre Pierre et Marie Curie, avenue Bouzenad Salem, 16000 Algiers, Algeria
- Faculty of medicine, University of Algiers Benyoucef Benkhedda, Algeria
| |
Collapse
|
5
|
Belhadef S, Arab A, Belmadi M, Beninal M, Bacha N, Abdallah R, Mechta K, Dahmane A, Mahfouf H, Oukkal M, Bouzid K, Faraqun S, Bentabak K, Younes SA. P-9 A randomized study of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 as first-line treatment for unresectable metastatic colorectal cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
6
|
Tounsi N, Djerdjouri B, Bouzid C, Bentabak K. Correlation of adenosine deaminase operating under nitro-oxidative stress with tumor and vascularization in patients with advanced gallbladder carcinoma. J Appl Biomed 2019; 17:175-183. [PMID: 34907699 DOI: 10.32725/jab.2019.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2019] [Accepted: 08/20/2019] [Indexed: 11/05/2022] Open
Abstract
This study investigates serum redox status and adenosine catabolism markers in relation to tumor and angiogenesis, in patients with gallbladder carcinoma (GBC). The level of adenosine deaminase (ADA) and xanthine oxidase (XO) activities, nitrites (NO2-), glutathione (GSH) and malondialdehyde (MDA) were measured in sera of 40 GBC patients and 40 healthy donors. In parallel, 15 tumors at TNM stage IV were scored for CD34 expression and microvessel density (MVD). The results showed that XO and ADA activities, nitrites and MDA levels enhanced by 1.26 (p < 0.01), 2.69, 2.0, and 3.2-fold (p < 0.001), respectively, while those of GSH decreased by 44.6% (p < 0.001). According to receiver operating characteristic (ROC) curve, the optimal cut-off for XO, ADA, MDA, GSH and nitrites were 5.41U/l, 17.02 U/l, 3.72 μM, 36.91 μM and 21.21 μM, respectively. Spearman correlation revealed that ADA activity correlated to nitrites levels (r = 0.3419, p < 0.05) and XO activity (r = 0.5487, p < 0.001). Multivariate binary logistic regression analysis revealed that MDA (OR = 5.78, p < 0.05), ADA (OR = 1.28, p < 0.001) and XO (OR = 2.81, p < 0.05) correlated positively to GBC. CD34 was up expressed in 73.3% of tumors at intermediate to high levels. Multiple regression analysis showed that ADA affected MVD (r = 0.604, p < 0.01). The results suggest that high MDA/GSH ratio is a potential biomarker of GBC. In addition, the oxidative adenosine catabolism indicated that active purine salvage pathway could support tumor progression by sustaining angiogenesis.
Collapse
Affiliation(s)
- Nabila Tounsi
- University of Sciences and Technology Houari Boumediene, Faculty of Biological Sciences, Laboratory of Cellular and Molecular Biology, Algiers, Algeria
| | - Bahia Djerdjouri
- University of Sciences and Technology Houari Boumediene, Faculty of Biological Sciences, Laboratory of Cellular and Molecular Biology, Algiers, Algeria
| | - Chafik Bouzid
- Mustapha Pacha Hospital, Public Health Center Pierre and Marie Curie, Department of Oncological Surgery A, Algiers, Algeria
| | - Kamel Bentabak
- Mustapha Pacha Hospital, Public Health Center Pierre and Marie Curie, Department of Oncological Surgery A, Algiers, Algeria
| |
Collapse
|
7
|
Faraoun SA, Boudjella MEA, Debzi N, Afredj N, Guerrache Y, Benidir N, Bouzid C, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: a prospective analysis of hepatic vein obstruction on ultrasonography, multidetector-row computed tomography and MR imaging. ACTA ACUST UNITED AC 2016; 40:1500-9. [PMID: 25687630 DOI: 10.1007/s00261-015-0380-5] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
PURPOSE The goal of this study was to prospectively describe the imaging presentation of hepatic vein (HV) obstruction in patients with Budd-Chiari syndrome (BCS) on duplex and color Doppler ultrasonography (DCD-US), multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI). MATERIALS AND METHODS A total of 176 patients with primary BCS (mean age, 33 years; 101 women) were prospectively included. BCS diagnosis was made by direct visualization of HV and/or upper portion of the inferior vena cava (IVC) obstruction on DCD-US and/or MDCT and/or MRI. Location (right, middle, and left HV), type (thrombus, stenosis, or both), and age (recent vs. long-standing) of HV obstruction were described on each imaging examination. RESULTS HV obstruction was a constant (100%) finding and associated with IVC abnormalities in 51/176 (28.98%) patients. Obstruction of the three HVs was present in 158/176 (89.77%) patients. The prevalences of right, middle, and left HV thrombus were 151/169 (89.35%), 146/169 (86.39%), and 111/169 (65.68%), respectively. Long-standing HV thrombus was observed in more than 92% of patients on the three imaging methods. Agreement between DCD-US, MDCT, and MRI was perfect in the identification of long-standing HV thrombus (κ = 0.9); this agreement was slight to moderate in revealing the type of HV abnormality (i.e., fibrotic cord and non-visible HV). CONCLUSION Our results indicate that BCS is a chronic and insidious disease, more often discovered at an advanced stage. These results should warrant further evaluation of screening strategies in patients with risk factors for BCS to identify the disease at an early stage.
Collapse
Affiliation(s)
- Sid Ahmed Faraoun
- Department of Radiology, Centre Pierre et Marie Curie, Place du 1er Mai, 16016, Alger, Algeria,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Faraoun SA, Boudjella MEA, Debzi N, Benidir N, Afredj N, Guerrache Y, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: an update on imaging features. Clin Imaging 2016; 40:637-46. [PMID: 27317208 DOI: 10.1016/j.clinimag.2016.01.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Revised: 01/05/2016] [Accepted: 01/15/2016] [Indexed: 12/15/2022]
Abstract
Budd-Chiari syndrome (BCS) is a rare cause of portal hypertension and liver failure. This condition is characterized by an impaired hepatic venous drainage. The diagnosis of BCS is based on imaging, which helps initiate treatment. Imaging findings can be categorized into direct and indirect signs. Direct signs are the hallmarks of BCS and consist of visualization of obstructive lesions of the hepatic veins or the upper portion of the inferior vena cava. Indirect signs, which are secondary to venous obstruction, correspond to intra- and extrahepatic collateral circulation, perfusion abnormalities, dysmorphy and signs of portal hypertension.
Collapse
Affiliation(s)
- Sid Ahmed Faraoun
- Department of Radiology, Pierre and Marie Curie Center, Place du 1er Mai, 16016, Algiers, Algeria.
| | | | - Nabil Debzi
- Department of Hepatology, CHU Mustapha, Place du 1er Mai, 16016, Algiers, Algeria.
| | | | - Nawel Afredj
- Department of Hepatology, CHU Mustapha, Place du 1er Mai, 16016, Algiers, Algeria.
| | - Youcef Guerrache
- Department of Radiology, Pierre and Marie Curie Center, Place du 1er Mai, 16016, Algiers, Algeria.
| | - Kamel Bentabak
- Department of Durgery, Centre Pierre et Marie Curie, Place du 1er Mai, 16016, Algiers, Algeria.
| | - Philippe Soyer
- Université Sorbonne Paris Cité, Diderot Paris 7, 10 Avenue de Verdun, 75010, Paris, France.
| | - Salah Eddine Bendib
- Department of Radiology & Université Benyoucef Benkhedda d'Alger, Pierre and Marie Curie Center, Place du 1er Mai, 16016, Algiers, Algeria.
| |
Collapse
|
9
|
Afredj N, Guessab N, Nani A, Faraoun SA, Ouled Cheikh I, Kerbouche R, Hannoun D, Amir ZC, Ait Kaci H, Bentabak K, Plessier A, Valla DC, Cazals-Hatem V, Denninger MH, Boucekkine T, Debzi N. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol 2015; 7:903-909. [PMID: 25937867 PMCID: PMC4411532 DOI: 10.4254/wjh.v7.i6.903] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/26/2014] [Revised: 08/29/2014] [Accepted: 03/05/2015] [Indexed: 02/06/2023] Open
Abstract
AIM: To study the clinical presentation of Budd-Chiari syndrome (BCS) and identify the aetiologies of this disease in Algeria.
METHODS: Patients with BCS, hospitalised in our unit from January 2004 until June 2010 were included and the aetiological factors were assessed. Patients presenting a BCS in the setting of advanced-stage cirrhosis or a liver transplantation were excluded from the study. The diagnosis was established when an obstruction of hepatic venous outflow (thrombosis, stenosis or compression) was demonstrated. We diagnosed myeloproliferative disease (MPD) by bone marrow biopsy and V617F JAK2 mutation. Anti-phospholipid syndrome (APLS) was detected by the presence of anticardiolipin antibodies, anti-β2 glycoprotein antibodies and Lupus anticoagulant. We also detected paroxysmal nocturnal haemoglobinuria (PNH) by flow cytometry. Celiac disease and Behçet disease were systematically investigated in our patients. Hereditary anticoagulant protein deficiencies were also assessed. We tested our patients for the G20210A mutation at Beaujon Hospital. Imaging procedures were performed to determine a local cause of BCS, such as a hydatid cyst or a liver tumour.
RESULTS: One hundred and fifteen patients were included. Mean follow up: 32.12 mo. Mean age: 34.41 years, M/F = 0.64. Chronic presentation was frequent: 63.5%. The revealing symptoms for the BCS were ascites (74.8%) and abdominal pain (42.6%). The most common site of thrombosis was the hepatic veins (72.2%). Involvement of the inferior vena cava alone was observed in 3 patients. According to the radiological investigations, BCS was primary in 94.7% of the cases (n = 109) and secondary in 5.2% (n = 6). An aetiology was identified in 77.4% of the patients (n = 89); it was multifactorial in 27% (n = 31). The predominant aetiology of BCS in our patients was a myeloproliferative disease, observed in 34.6% of cases. APLS was found in 21.7% and celiac disease in 11.4%. Other acquired conditions were: PNH (n = 4), systemic disease (n = 6) and inflammatory bowel disease (n = 5). Anticoagulant protein deficiency was diagnosed in 28% of the patients (n = 18), dominated by protein C deficiency (n = 13). Secondary BCS was caused by a compressing hydatic cyst (n = 5) and hepatocellular carcinoma (n = 1).
CONCLUSION: The main aetiologic factor of BCS in Algeria is MPD. The frequency of celiac disease justifies its consideration when BCS is diagnosed in our region.
Collapse
|
10
|
Sulpice L, Desfourneaux V, Rayar M, Meunier B, Lakehal M, Bentabak K, Graba A, Boudjema K. Techniques de transplantation hépatique chez l’adulte. ACTA ACUST UNITED AC 2013. [DOI: 10.1016/s0246-0424(12)57364-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
11
|
Mahfouf H, Djeddi H, Belhadef S, Bouzid K, Bentabak K. Capecitabine combined with oxaliplatin (XELOX) as first-line chemotherapy in colorectal cancer with liver metastases. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e15146 Background: The combination of 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (I-OHP) was shown to be both more active against metastatic colorectal carcinoma and better tolerated. Methods: Chemotherapy-naive patients confirmed histologic colorectal cancer with liver metastases, adequate born morrow, renal and hepatic function, measurable diseases were considered eligible for the study. Treatment: Six cycles of oxaliplatin 85 mg/m2 day1 plus capecitabine 1250 mg/m2 twice daily days 1–14 every 21 days Results: Twenty six patients were evaluated for safety and efficacy (male/female, 12/14). Median age was 53 years (range 32–75 years). A total of 142 cycles have been administered: median per patient 4 (range 3–6 courses). In an intent-to-treat efficacy analysis, One complete and ten partial responses were achieved [overall objective response rate (ORR): 42, 3%; whereas 7 patients had stable disease and eight patients had progressive disease. Seven patients from 11 with objective response underwent major liver resection: 2 bisegmentectomy, 1 left lobectomy, 4 segmentectomy, and receive the same regimen of chemotherapy (Six cycles) as an adjuvant treatment and still alive without recurrence. The overall survival (OS) was 19, 2 months. The median response duration was 7 months. The median time to progression (TTP) was 8 months. The grade 3 toxicities were diarrhea (7%), fatigue (4%), neurotoxicity (2%), neutropenia (2%), and thrombocytopenia 4%). Conclusions: The combination of oxaliplatin and capecitabine is safe and has a promising activity in patients with liver metastatic colorectal carcinoma. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- H. Mahfouf
- EHS Pierre & Marie Curie, Algiers, Algeria
| | - H. Djeddi
- EHS Pierre & Marie Curie, Algiers, Algeria
| | | | - K. Bouzid
- EHS Pierre & Marie Curie, Algiers, Algeria
| | | |
Collapse
|
12
|
Oukkal M, Kara F, Difi S, Bouzidi D, Bentabak K, Graba A, Smail N, Ait Kaci N, Baba Ahmed R, Bouzid K. Bevacizumab plus FOLFOX7 as first line treatment in patients with advanced colorectal cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e15092 Background: Bevacizumab a monoclonal antibody against vascular endothelial growth factor (VEGF) has shown in combination with chemotherapy a significant survival improvement in pts with advanced colorectal cancer (F. Kabbinavar JCO 2005 and H. Hurwitz NEJM 2004). In this study we investigated the safety and the efficacy of the addition of bevacizumab to FOLFOX7 regimen in pts with metastatic colorectal cancer. Methods: Inclusion criteria: Histological proven colorectal carcinoma, measurable disease at time of inclusion, no prior chemotherapy (adjuvant chemotherapy allowed), no CNS metastasis, no peripheral neuropathy, no other serious concomitant illness, ECOG PS ≤ 2, Urine dipstick of proteinuria <2+, adequate renal and liver function, good bone marrow reserve and informed consent. Pts received bimonthly Oxaliplatin 130 mg/m2 D1, Folinic acid 400 mg/m2 D1, Fluorouracil 2400 mg/m2 46 hours continuous infusion and Bevacizumab 5mg/kg D3 Results: From April 2005 to June 2007, 47 pts (M/F = 28/19, colon/rectum = 28/19) were enrolled in the study. Median age is 52,7 years old (32–74). They received 452 cycles, median=7 range (1–18). All pts were evaluable for toxicity and survival and 46 for responses. Complete response (CR) was achieved in 3 pts (6.6%), partial response (PR) in 28 pts (60.8%), stable disease in 4 pts (8.7%) and progressive disease in 11 pts (24%). The overall response rate (ORR=CR+PR) is 67.3%. Severe toxicity (CTC/NCI ¾ Grade) related to chemotherapy was neuropathy 5.3%, neutropenia 8.4%, anaemia 3.3%, thrombocytopenia 1.8%, vomiting 8.2%, diarrhoea 2.9%, stomatis 4.9% and allergy 0.7%. Toxicity related to Bevacizumab was bleeding CTCNCI grade 1 and 2 in 40.8%, hypertension grade 1 qnd 2 in 3.7% qnd grqde 3 in 0.2. proteinuria grade and 2 in 13.7%. 1 case of phlebitis and 1 case of Bevacizumab allergy Conclusions: Bevacizumab and FOLFOX7 combination is a promising treatment with high efficacy and safety profile for pts with advanced colorectal cancer No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. Oukkal
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - F. Kara
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - S. Difi
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - D. Bouzidi
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - K. Bentabak
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - A. Graba
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - N. Smail
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - N. Ait Kaci
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - R. Baba Ahmed
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| | - K. Bouzid
- Pierre & Marie Curie Center, Algiers, Algeria; Mustapha Bacha Hospital, Algiers, Algeria; Mohamed Lamine Dabaghine Hospital, Algiers, Algeria
| |
Collapse
|
13
|
Bentabak K, Graba A, Boudjema K, Griène B, Debzi N, Bekkouche N, Yahiatène S, Fellah N, Benmoussa D, Faraoun SA, Bodin JM, Lakehal M, Bendib SE, Boucekkine T. Adult-to-Adult Living Related Liver Transplantation: Preliminary Results of the Hepatic Transplantation Group in Algiers. Transplant Proc 2005; 37:2873-4. [PMID: 16182839 DOI: 10.1016/j.transproceed.2005.05.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
INTRODUCTION In the absence of cadaveric grafts, a living donor liver transplant program was started in Algeria in February 2003. The aim of this study is to report the preliminary results. PATIENTS AND METHODS From February 2003 to September 2004, eight adult-to-adult living related liver transplantations were performed. The donors were six women and two men of mean age of 25 years (range, 18 to 48 years). Right hepatectomy was performed in seven patients and left hepatectomy in one patient. The recipients were four women and four men of mean age 33 years (range, 16 to 56 years). Follow-up ranged from 1 month to 18 months (median 7 months). RESULTS All donors survived the procedure. In the immediate postoperative period, two donors experienced complications. One donor underwent reoperation for hemorrhage and one suffered partial portal vein thrombosis, which was treated medically. The eight donors are alive at home without any late complications. One recipient died on postoperative day 43 due to sepsis. Among the seven other recipients, two experienced complications: one bilioma in relation to a biliary-intestinal fistula and one thrombosis of the splenic vein with a left portal embolus. At present the seven recipients are alive with normal liver function and without complications. CONCLUSION Our results are comparable to other reports suggesting that adult-to-adult living related liver transplantation is feasible with no mortality and low morbidity in donors. However, it is important to develop a cadaveric liver transplant program.
Collapse
Affiliation(s)
- K Bentabak
- General Oncologic Surgery and Liver Transplantation Services, Centre Pierre et Marie Curie, University of Algiers, Algiers, Algeria.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|